Hypnosis and Attention in Patients With a Neurological Disease (Stroke, Traumatic Brain Injury and Multiple Sclerosis)
Recruiting · NCT07256704 · Interventional (participants receive a specific treatment) · Lead sponsor: Luzerner Kantonsspital
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
This feasibility study investigates the potential of hypnosis as a complementary therapy for improving attentional deficits and reducing fatigue in patients with neurological conditions such as stroke, traumatic brain injury (TBI), and multiple sclerosis (MS). These patients often experience reduced spontaneous visual exploration and impaired functional independence despite current rehabilitation approaches. By integrating hypnosis with standard care and using EEG to monitor brain activity during hypnosis and sham-hypnosis sessions, this trial aims to evaluate the feasibility, acceptability, and preliminary efficacy of hypnosis in enhancing attention and reducing fatigue.
Who can take part
Inclusion criteria
- ICD-10 Diagnosis of stroke, TBI or MS
- Admitted to the inpatient and/or outpatient in the Clinic for Neurology and Neurorehabilitation
- Age 18 years old or older
- Understanding the German language
- Written informed consent
Exclusion criteria
- \- Psychiatric disease
- Exclusion criteria for the EEG:
- \- Scalp or skin conditions that interfere with EEG electrode placement (e.g. open wounds, infections, severe psoriasis) Implanted medical or neurostimulation devices that interfere with EEG electrode placement (e.g. deep brain stimulators, cochlear implants)
Where it is running
1 location listed.
- Luzerner Kantonsspital - Lucerne, Switzerland